Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Wayne Triner, Albany Medical College
ClinicalTrials.gov Identifier:
NCT01374295
First received: June 7, 2011
Last updated: March 21, 2014
Last verified: June 2011
  Purpose

In order to compare two different forms of patient education; patients who receive Lortab medication or prescription during their ED visit are randomized to receive either standard patient education (from healthcare provider) or video assisted education. After education, patient completes a survey, estimated to take 5 minutes to complete.


Condition Intervention
Non-critical Emergency Room Patients Receiving Lortab Medication or Prescription During Their Emergency Room Visit
Other: video
Other: standard education

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver)
Official Title: Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge: A Randomized Control Study

Further study details as provided by Albany Medical College:

Primary Outcome Measures:
  • patient satisfaction and knowledge [ Time Frame: survey is completed immediately after education, estimated time to complete survey is 5 minutes ] [ Designated as safety issue: No ]
    comparison of patient completed survey following education via standard format or 3 minute video


Enrollment: 120
Study Start Date: March 2011
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: video
If randomized to this arm patient watches a 3 minute video
Other: video
watch a 3 minute video
Active Comparator: standard education
If randomized to this arm patient receives standard verbal education from healthcare provider.
Other: standard education
Receives standard verbal education from healthcare provider

Detailed Description:

The purpose of this study is to compare different methods of teaching patients about their prescription medicines. It is possible that certain teaching methods are better than others at educating patients.

Patients who receive Lortab medication or prescription during their ED visit and agree to the study are randomized to receive either standard patient education (from healthcare provider) or watch a 3 minute video. After the medication teaching has been provided the patient is given the medicine and a asked to complete a ten-question survey. This takes approximately five minutes and asks the patient to rate the quality of the information received.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • non-critical emergency room patients being prescribed Lortab
  • age 18 year or older

Exclusion Criteria:

  • emergency room patients not receiving Lortab as their first prescribed medication
  • age less than 18 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01374295

Locations
United States, New York
Albany Medical Center
Albany, New York, United States, 12208
Sponsors and Collaborators
Albany Medical College
  More Information

No publications provided

Responsible Party: Wayne Triner, Professor Dept. of Emergency Medicine, Albany Medical College
ClinicalTrials.gov Identifier: NCT01374295     History of Changes
Other Study ID Numbers: 2981, Lortab
Study First Received: June 7, 2011
Last Updated: March 21, 2014
Health Authority: United States: AMC Institutional Review Board

Additional relevant MeSH terms:
Emergencies
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on July 24, 2014